KEQU vs LCUT vs ACCO vs HELE

For growth investors, Kewaunee Scientific Corporation (KEQU) is the stronger pick with 18.

0% revenue growth year-over-year, versus -8. 5% for ACCO Brands Corporation (ACCO). ACCO Brands Corporation (ACCO) offers the better valuation at 9. 2x trailing P/E (4. 8x forward), making it the more compelling value choice. Analysts rate Lifetime Brands, Inc. (LCUT) a "Hold" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, ACCO Brands Corporation (ACCO) is the cheapest at 9.

2x versus Kewaunee Scientific Corporation at 9. 5x. On forward P/E, ACCO Brands Corporation is actually cheaper at 4. 8x.

Over the past 5 years, Kewaunee Scientific Corporation (KEQU) delivered a total return of +202.

7%, compared to -88. 6% for Helen of Troy Limited (HELE). Over 10 years, the gap is even starker: KEQU returned +138. 9% versus HELE's -74. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Kewaunee Scientific Corporation (KEQU) is the lower-risk stock at 1.

09β versus Helen of Troy Limited's 1. 65β — meaning HELE is approximately 51% more volatile than KEQU relative to the S&P 500. On balance sheet safety, Helen of Troy Limited (HELE) carries a lower debt/equity ratio of 10% versus 139% for ACCO Brands Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Kewaunee Scientific Corporation (KEQU) is pulling ahead at 18.

0% versus -8. 5% for ACCO Brands Corporation (ACCO). On earnings-per-share growth, the picture is similar: ACCO Brands Corporation grew EPS 141. 5% year-over-year, compared to -827. 7% for Helen of Troy Limited. Over a 3-year CAGR, KEQU leads at 12. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Kewaunee Scientific Corporation (KEQU) is the more profitable company, earning 4.

7% net margin versus -50. 3% for Helen of Troy Limited — meaning it keeps 4. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KEQU leads at 7. 4% versus 3. 8% for LCUT. At the gross margin level — before operating expenses — HELE leads at 45. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, ACCO Brands Corporation (ACCO) trades at 4.

8x forward P/E versus 23. 8x for Kewaunee Scientific Corporation — 19. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACCO: 97. 0% to $8. 00.

In this comparison, ACCO (7.

1% yield), LCUT (2. 4% yield) pay a dividend. KEQU, HELE do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, ACCO Brands Corporation (ACCO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (7.

1% yield). Helen of Troy Limited (HELE) carries a higher beta of 1. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACCO: -35. 1%, HELE: -74. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (KEQU (Consumer Cyclical) and LCUT (Consumer Cyclical) and ACCO (Industrials) and HELE (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: KEQU is a small-cap high-growth stock; LCUT is a small-cap quality compounder stock; ACCO is a small-cap deep-value stock; HELE is a small-cap quality compounder stock. LCUT, ACCO pay a dividend while KEQU, HELE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.